Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 4 days, and 1 more · Every feed →

All 2,408Congress 78Executive branch 36Insiders 2,294
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

buys only · $250K+ · 2,408 trades

Trades
2,408
Buys 2,408 · Sells 0
People
667
Stocks
437
Disclosed value
$11.1B
range midpoints · Congress & executive
Filed late
303
  1. ▲ BUYAH Bio Fund II, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  2. ▲ BUYBenjamin A Horowitz 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  3. ▲ BUYAH Bio Fund III, L.P. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  4. ▲ BUYAH Equity Partners Bio II, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  5. ▲ BUYOrbiMed Capital GP VIII LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  6. ▲ BUYLuis Campos DirectorBWMX Betterware De Mexico, S.A.P.I. De C.V$768Kdisclosed Jul 29 · filed 2 days after the trade
  7. ▲ BUYOrbimed Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  8. ▲ BUYAH Equity Partners Bio III, L.L.C. 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  9. ▲ BUYCarl L Gordon DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade
  10. ▲ BUYMarc L Andreessen 10% ownerSCTX Scribe Therapeutics, Inc.$5Mdisclosed Jul 29 · filed 2 days after the trade
  11. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$255Kdisclosed Jul 28 · filed 1 day after the trade
  12. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.3Mdisclosed Jul 28 · filed 4 days after the trade
  13. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  14. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.8Mdisclosed Jul 28 · filed 4 days after the trade
  15. ▲ BUYPeter Kolchinsky DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  16. ▲ BUYAvoro Ventures LLC DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade
  17. ▲ BUYRA Capital Nexus Fund, L.P. DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  18. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  19. ▲ BUYAvoro Capital Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$35Mdisclosed Jul 28 · filed 4 days after the trade
  20. ▲ BUYBrien Raymond V O III DirectorCVBF Cvb Financial Corp$455Kdisclosed Jul 28 · filed the same day
  21. ▲ BUYRajeev M. Shah DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  22. ▲ BUYRA Capital Healthcare Fund LP DirectorARTV Artiva Biotherapeutics, Inc.$413Kdisclosed Jul 28 · filed 4 days after the trade
  23. ▲ BUYDurable Capital Partners LP 10% ownerGSHD Goosehead Insurance, Inc.$1.5Mdisclosed Jul 28 · filed 4 days after the trade
  24. ▲ BUYThomas M Moriarty EVP, M&A and Corporate AffairsACI Albertsons Companies, Inc.$2Mdisclosed Jul 28 · filed 1 day after the trade
  25. ▲ BUYBehzad Aghazadeh DirectorSCTX Scribe Therapeutics, Inc.$1.1Mdisclosed Jul 28 · filed 4 days after the trade